LRG Executive Director Sara Rothschild took part in a CME course produced by Medscape titled 'Improving Outcomes & Quality of Life in Advanced GIST: Discussing the Patient Journey and the Latest Data.'
Our most recent GIST Days of Learning (GDOLs) were in-person again! Deputy Director, Laura Occhiuzzi and Senior Director of Outreach & Engagement Diana Nieves traveled to San Diego and Miami to meet with GIST experts and members of our community.
In this webinar. Dr. Andrew Blakely, surgical oncologist, National Cancer Institute, Center for Cancer Research, NIH, discussed the basics of surgical removal of primary GISTs and considerations in multimetastatic disease.
In this webinar, “The Emerging Role of Circulating Tumor DNA in Gastrointestinal Stromal Tumor”, Dr. Bialick discussed recent data looking at treatment outcomes based off KIT resistant mutations identified by circulating tumor DNA in patients with GIST.
Life Fest has a roster of great GIST education programming but there's also time at the day's end to indulge in some local activities. Here's a list of some of the top attractions in NOLA.
Life Fest has a roster of great GIST education programming but there's also time at the day's end to indulge in some local cuisine. Here's a list of some of the top culinary experiences in NOLA.
It’s time to get ready for our Life Fest celebration in New Orleans! Here are the top ten reasons to attend.
Join the LRG team, renowned GIST experts, and fellow GISTers & family at Life Fest, July 29th-31st, in New Orleans, LA, and learn more about GIST in either of these two sessions: General or SDH.
The Life Raft Group held a virtual GIST Day of Learning (GDOL) in Washington, DC on April 27th, 2022. Top GIST specialists presented the latest on research and treatment options and provided a comprehensive review of the science behind GIST.
Join medical professionals and the patient advocacy community on Tuesday, April 26, 2022 for a CME conference, “Rare Cancers: Great Unmet Medical Needs” hosted by Columbia University Herbert Irving Comprehensive Cancer Center and the Jed Ian Taxel Foundation for Rare Cancer Research.